» Articles » PMID: 10594800

Predicting Renal Survival in Primary Focal Glomerulosclerosis from the Time of Presentation

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1999 Dec 14
PMID 10594800
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Predicting renal survival in primary focal glomerulosclerosis from the time of presentation.

Background: To predict the risk of developing chronic renal failure in patients with primary focal glomerulosclerosis (FGS) using predictors available at the time of presentation, a retrospective analysis was performed on 111 patients who were diagnosed at Christchurch Hospital from 1965 to 1998.

Methods: The predictors of outcome included age, gender, systolic and diastolic blood pressure, serum albumin, plasma creatinine, presence of hematuria, and amount of proteinuria (all at the time of presentation). An injury score (combination of percentage of sclerosed glomeruli and proportion of tubulointerstitial fibrosis) was derived from a review of the initial kidney biopsy. Log-logistic accelerated failure time parametric models were used.

Results: The median renal survival was 16.4 years (Kaplan-Meier estimate). The best single variable model was that using the proportion of tubulointerstitial fibrosis (global chi-square 55.99, P < 0.0001). However, inclusion of plasma creatinine significantly improved the fit of the model (global chi-square 65.04, P < 0.0001). This joint model was superior to the single-variable model. Both of the models were validated using jackknifing.

Conclusion: For a patient with primary FGS, these models can be used to predict the risk of developing chronic renal failure at any time and the median renal survival, given the proportion of tubulointerstitial fibrosis and plasma creatinine at the time of presentation.

Citing Articles

Clinical course and outcome of adult patients with primary focal segmental glomerulosclerosis with kidney function loss on presentation.

Jafry N, Sarwar S, Waqar T, Mubarak M World J Nephrol. 2024; 13(4):98932.

PMID: 39723357 PMC: 11572652. DOI: 10.5527/wjn.v13.i4.98932.


Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort.

Stamellou E, Nadal J, Hendry B, Mercer A, Bechtel-Walz W, Schiffer M Clin Kidney J. 2024; 17(7):sfae131.

PMID: 38989280 PMC: 11234294. DOI: 10.1093/ckj/sfae131.


Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review.

Catanese L, Rupprecht H, Huber T, Lindenmeyer M, Hengel F, Amann K Int J Mol Sci. 2024; 25(6).

PMID: 38542491 PMC: 10970781. DOI: 10.3390/ijms25063519.


Later Response to Corticosteroids in Adults With Primary Focal Segmental Glomerular Sclerosis Is Associated With Favorable Outcomes.

Rood I, Bavinck A, Lipska-Zietkiewicz B, Lugtenberg D, Schaefer F, Deegens J Kidney Int Rep. 2022; 7(1):87-98.

PMID: 35005317 PMC: 8720814. DOI: 10.1016/j.ekir.2021.10.016.


Focal Segmental Glomerulosclerosis in Paediatric Population of South Punjab Pakistan: A Tertiary Care Hospital Experience.

Safdar R, Mehar M, Khan A, Buzdar N Pak J Med Sci. 2021; 37(2):510-514.

PMID: 33679941 PMC: 7931269. DOI: 10.12669/pjms.37.2.3535.